“Pharmaceutical and Biomedical Portfolio Management in a Changing Global Environment” explores some of the critical forces at work today in the complex endeavour of pharmaceutical and medical product development. Written by experienced professionals, and including real-world approaches and best practice examples, this new title addresses three key areas—small molecules, large molecules, and medical devices-and provides hard-to-find, consolidated information relevant to and needed by pharmaceutical, biotech, and medical device company managers.
